Recurrent SARS-CoV-2 Omicron broadly neutralizing humanized antibodies in different single human V H 1-2-rearranging mouse models
Proceedings of the National Academy of Sciences · 31.03.2026 · 123 (13)
DOI: 10.1073/pnas.2537053123 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 23.03.2026. Verfasst von Himanshu Batra und 27 weiteren Autor:innen. Beteiligte Einrichtung: Howard Hughes Medical Institute, Boston Children's Hospital, Boston, MA 02115. Hauptthemen laut MEDLINE: SARS-CoV-2, Antibodies, Neutralizing, Antibodies, Viral, COVID-19. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Massachusetts Consortium on Pathogen Readiness (MCPR), Ministry of Science and Technology of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
During V(D)J recombination, antibody diversity is enhanced by nontemplated junctional modifications that generate immensely diverse heavy chain (HC) and light chain (LC) complementarity-determining 3 antigen-contact regions (CDR3s). We previously developed a mouse model that generates diverse antibody repertoires by rearranging a single human V H 1-2 and Vκ1-33, associated with highly diverse CDR3s generated by V(D)J recombination with mouse Ds and/or Js. Immunization of this model with SARS-CoV-2 D614G spike elicited an antibody that potently neutralized SARS-CoV-2 variants through Omicron BA.2.754. Here, we report a related mouse model in which a single V H 1-2 rearranges to human D3-3 and J H 6, generating diverse HC-CDR3s much longer on average than those of our prior model. Omicron BA.4/.5 spike-ferritin nanoparticle-immunization of the new model elicited four highly related humanized antibodies that potently neutralize downstream Omicron subvariants. All four antibodies had 12 AA HC-CDR3s with two aromatic amino acids that engage an epitope comprising a hydrophobic patch opened-up by early Omicron lineage mutations and conserved in subsequent variants. Immunization of our prior, shorter CDR3-based model, elicited slightly less potent neutralizing antibodies that bound the same Omicron epitope, and were similar in all other aspects to those from the long, fully human CDR3 model. One tested antibody from each set reduced lung viral titers in a mouse-adapted BQ1.1 challenge. The antibodies we describe are related in their epitope recognition to recently described antibodies from Omicron-infected humans. These studies validate the utility of single human V H - and Vκ-rearranging mice for discovering humanized antibodies that neutralize emerging pathogens.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Howard Hughes Medical Institute, Boston Children's Hospital, Boston, MA 02115.
- Program in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, MA 02115.
- Department of Genetics, Harvard Medical School, Boston, MA 02115.
- Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710.
- Department of Surgery, Duke University, Durham, NC 27710.
- Department of Integrative Immunobiology, Duke University School of Medicine, Durham, NC 27710.
ORCID-Profile: Fanchong Jian, Aimee Chapdelaine Williams, Ralph S Baric, Yunlong Cao, Bing Chen
Förderung
- Massachusetts Consortium on Pathogen Readiness (MCPR)
- Ministry of Science and Technology of China
- National Natural Science Foundation of China
- NIAID NIH HHS
- HHS | NIH | NIAID | Division of Microbiology and Infectious Diseases (DMID)
- Boya Postdoctoral Fellowship Program of Peking University
- Bill & Melinda Gates Foundation
- Changping Laboratory (CPL)
Zitieren
APA
Batra, H., Luo, S., Saunders, K. O., Higgins, J. S., Jian, F., Zhang, J., Kibria, M. G., Jonaid, G. M., Zhou, Q. J., Eaton, A., Cronin, K., Mallory, M. L., Mattocks, M., Edwards, R. J., Parks, R., Lee, E. M., Ye, A. Y., Williams, A. C., Jung, G., …, & Alt, F. W. (2026). Recurrent SARS-CoV-2 Omicron broadly neutralizing humanized antibodies in different single human V H 1-2-rearranging mouse models. Proceedings of the National Academy of Sciences, 123(13). https://doi.org/10.1073/pnas.2537053123
Vancouver
Batra H, Luo S, Saunders KO, Higgins JS, Jian F, Zhang J, et al. Recurrent SARS-CoV-2 Omicron broadly neutralizing humanized antibodies in different single human V H 1-2-rearranging mouse models. Proceedings of the National Academy of Sciences. 2026;123(13). doi:10.1073/pnas.2537053123
BibTeX
@article{Batra2026,
author = {Batra, Himanshu and Luo, Sai and Saunders, Kevin O and Higgins, Jaclyn S and Jian, Fanchong and Zhang, Jun and Kibria, Md Golam and Jonaid, G M and Zhou, Qingchen J and Eaton, Amanda and Cronin, Kenneth and Mallory, Michael L and Mattocks, Melissa and Edwards, Robert J and Parks, Robert and Lee, Esther M and Ye, Adam Yongxin and Williams, Aimee Chapdelaine and Jung, Geeyoun and Mansouri, Katayoun and Alam, S Munir and Montefiori, David C and Tian, Ming and Baric, Ralph S and Cao, Yunlong and Haynes, Barton F and Chen, Bing and Alt, Frederick W},
title = {Recurrent SARS-CoV-2 Omicron broadly neutralizing humanized antibodies in different single human V H 1-2-rearranging mouse models},
journal = {Proceedings of the National Academy of Sciences},
year = {2026},
volume = {123},
number = {13},
doi = {10.1073/pnas.2537053123}
}
EUVIMED